These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8483806)

  • 21. Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium.
    Jacques D; Abdel-Samad D
    Can J Physiol Pharmacol; 2007 Jan; 85(1):43-53. PubMed ID: 17487244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y receptor in vascular smooth muscle.
    Shigeri Y; Mihara S; Fujimoto M
    J Neurochem; 1991 Mar; 56(3):852-9. PubMed ID: 1847185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
    Kahl U; Langel U; Bartfai T; Grundemar L
    Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.
    Zhou Y; Shi W; Luo H; Yue R; Wang Z; Wang W; Liu L; Wang WE; Wang H; Zeng C
    Hypertens Res; 2015 Dec; 38(12):807-12. PubMed ID: 26178154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists.
    Evéquoz D; Grouzmann E; Beck-Sickinger AG; Brunner HR; Waeber B
    Experientia; 1994 Oct; 50(10):936-8. PubMed ID: 7957768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM; Hill SJ; Selbie LA
    Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
    Abounader R; Villemure JG; Hamel E
    Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype.
    Cadieux A; Pheng LH; St-Pierre S; Fournier A; Benchekroun MT
    Regul Pept; 1993 Jul; 46(3):557-64. PubMed ID: 8210515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
    Jackson EK; Kochanek SJ; Gillespie DG
    Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
    Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
    Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
    Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
    J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
    DiMaggio DA; Farah JM; Westfall TC
    Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for neuropeptide Y in rat iridial arterioles.
    Newhouse MJ; Hill CE
    Am J Physiol; 1997 Nov; 273(5):H2119-27. PubMed ID: 9374743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of vasoconstriction mediated by neuropeptide Y Y2 receptors in arterioles of the guinea-pig small intestine.
    Neild TO; Lewis CJ
    Br J Pharmacol; 1995 May; 115(2):220-1. PubMed ID: 7670724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.